Standards & Guidelines
-
Peri-operative Management of Patients with Pulmonary Hypertension and Right Heart Failure Undergoing Surgery23 June 2022
This document represents the first international consensus statement for the perioperative management of patients with pulmonary hypertension and right heart failure.
-
SCAI SHOCK Stage Classification Expert Consensus UpdateA Review and Incorporation of Validation Studies31 January 2022
In January 2022, ISHLT endorsed this updated document from the Society for Cardiovascular Angiography and Interventions (SCAI) regarding shock stage classification.
-
Evaluation and Management of Patients with Chronic Thromboembolic Pulmonary Hypertension - Consensus Statement from ISHLT2 August 2021
This document is a literature review of chronic thromboembolic pulmonary hypertension. Due to the limited number of comparative trials in this field, the document includes expert opinion rather than recommendations based on levels of evidence.
-
ISHLT Consensus Document on Lung Transplantation in Patients with Connective Tissue Disease: Part IEpidemiology, Assessment of Extrapulmonary Conditions, Candidate Evaluation, Selection Criteria, and Pathology Statements28 July 2021
This document clarifies disease definitions, describes the extrapulmonary manifestations requiring consideration before LTX, and outlines contraindications to transplantation allowing risk stratification during evaluation and selection of LTX candidates.
-
International Consensus Recommendations for Anesthetic and Intensive Care Management of Lung TransplantationAn EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST Approved Document26 July 2021
This joint endeavor by EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST identifies potentially modifiable perioperative risks that provide novel opportunities for improved anesthesia and intensive care management strategies.
-
Consensus Document for the Selection of Lung Transplant Candidates: An Update from ISHLT24 July 2021
This document assists providers caring for patients with pulmonary disease identify potential candidates for LTX, optimize referral timing of these patients to LTX centers, and provide LTX centers with a framework for evaluating and selecting candidates.
-
ISHLT Consensus Statement for the Selection and Management of Pediatric and Congenital Heart Disease Patients on Ventricular Assist DevicesEndorsed by the American Heart Association19 May 2021
This consensus document was developed to address the selection and management of pediatric and congenital heart disease (CHD) patients undergoing VAD implantation.
-
2021 ACC/AHA Key Data Elements and Definitions for Heart FailureA Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards23 March 2021
Heart failure (HF) data standards are of critical importance, now more than ever. These data elements are intended to be useful across various categories related to the treatment of HF.
-
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart FailureA Report of the ACC/AHA Task Force on Performance Measures2 November 2020
Developed as an update to the existing 2011 performance measures set, this document describes performance measures for heart failure and developing new measures to evaluation patient care based on the 2017 ACC/AHA/HFSA heart failure guideline update.
-
ISHLT Consensus Statement for the Standardization of Bronchoalveolar Lavage in Lung Transplantation14 July 2020
This ISHLT Consensus Document on Bronchoalveolar lavage (BAL) standardization aims to enhance standardization and multi-center collaboration within the international LTX community and enable improvement and development of new BAL-based diagnostics.
-
Report from the 2018 Consensus Conference on Immunomodulating Agents in Thoracic TransplantationAccess, Formulations, Generics, Therapeutic Drug Monitoring, and Special Populations9 July 2020
The aim of this consensus document is to address concerns generic drug immunosuppression, expand on the challenges and barriers, and provide therapeutic considerations for practitioners who manage cardiothoracic transplant patients.
-
Donor Heart and Lung Procurement: A Consensus Statement21 April 2020
This international consensus statement is designed to serve as a guide for physicians, surgeons, and other providers who manage donors to best optimize the clinical status for the procurement of both heart and lungs for transplantation.
-
Utilization of Hepatitis C Virus–Infected Organ Donors in Cardiothoracic TransplantationAn ISHLT Expert Consensus Statement8 March 2020
The advent of therapies for treatment of hepatitis C virus (HCV) has allowed for the re-exploration of the use of HCV-positive donors for organ transplantation. This consensus document represents the current state of knowledge and expertise in this area.
-
2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology SpecialistsA Report of the ACC Competency Management Committee1 March 2020
This Lifelong Learning Statement addresses the competencies required of advanced heart failure and transplant cardiology (AHFTC) specialists and complements formal AHFTC fellowship training.
-
ISHLT Consensus Statement on Donor Organ Acceptability and Management in Pediatric Heart Transplantation31 January 2020
This statement evaluates reasons for discarding donor hearts and makes recommendations on their acceptance in an effort to ensure no usable donor heart is discarded, waitlist mortality is reduced, and post-transplant survival is not adversely impacted.
-
AATS/ISHLT Guidelines on Selected Topics in Mechanical Circulatory Support23 January 2020
Developed by a writing committee of 25 surgeons and 10 cardiologists, this consensus guidelines document focuses on selected topics in patient management.
-
Initial Skin Cancer Screening for Solid Organ Transplant Recipients in the United StatesDelphi Method Development of Expert Consensus Guidelines10 September 2019
A panel of U.S. dermatologists and transplant physicians conducted surveys to establish skin cancer screening recommendations for SOTR. These guidelines prioritize and emphasize the need for screening for SOTR at greatest risk for skin cancer.
-
2019 Updated Consensus Statement on the Diagnosis and Treatment of Pediatric Pulmonary Hypertension21 June 2019
This 2019 update to the 2016 consensus recommendations was created to deliver an updated, comprehensive, practical guidelines for healthcare providers addressing the specifics of PH and PVD in children and young adults.
-
2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy9 May 2019
This statement is intended to help cardiologists and other health care professionals involved in the care of adult and pediatric patients with arrhythmogenic cardiomyopathy by providng recommendations for evlauation and management.
-
HFSA/SAEM/ISHLT Clinical Expert Consensus Document on the Emergency Management of Patients with Ventricular Assist Devices1 May 2019
This consensus document represents a collaborative effort by HFSA, SAEM, and ISHLT to educate practicing clinicians about the emergency management of patients with ventricular assist devices.
- 1
- 2 (current)
- 3
- 4
- 5